Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference34 articles.
1. Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score;Bsteh;Eur. J. Neurol.,2021
2. Multiple sclerosis, disease-modifying therapies and COVID-19: a systematic review on immune response and vaccination recommendations;Cabreira;Vaccines,2021
3. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation;Charlson;J. Chronic. Dis.,1987
4. An update on the safety of treating relapsing-remitting multiple sclerosis;Chisari;Expert Opin. Drug Saf.,2019
5. Rituximab for the treatment of multiple sclerosis: a review;Chisari;J. Neurol.,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review;Frontiers in Immunology;2024-04-05
2. COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece;Journal of Clinical Medicine;2023-08-23
3. Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians;Neurologia i Neurochirurgia Polska;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3